Chapter/Section Purchase

Table of Contents
1 Research Methodology and Statistical Scope
1.1 Market Definition and Statistical Scope of Migraine Therapeutics
1.2 Key Market Segments
1.2.1 Migraine Therapeutics Segment by Type
1.2.2 Migraine Therapeutics Segment by Application
1.3 Methodology & Sources of Information
1.3.1 Research Methodology
1.3.2 Research Process
1.3.3 Market Breakdown and Data Triangulation
1.3.4 Base Year
1.3.5 Report Assumptions & Caveats
2 Migraine Therapeutics Market Overview
2.1 Global Market Overview
2.1.1 Global Migraine Therapeutics Market Size (M USD) Estimates and Forecasts (2019-2030)
2.1.2 Global Migraine Therapeutics Sales Estimates and Forecasts (2019-2030)
2.2 Market Segment Executive Summary
2.3 Global Market Size by Region
3 Migraine Therapeutics Market Competitive Landscape
3.1 Global Migraine Therapeutics Sales by Manufacturers (2019-2024)
3.2 Global Migraine Therapeutics Revenue Market Share by Manufacturers (2019-2024)
3.3 Migraine Therapeutics Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.4 Global Migraine Therapeutics Average Price by Manufacturers (2019-2024)
3.5 Manufacturers Migraine Therapeutics Sales Sites, Area Served, Product Type
3.6 Migraine Therapeutics Market Competitive Situation and Trends
3.6.1 Migraine Therapeutics Market Concentration Rate
3.6.2 Global 5 and 10 Largest Migraine Therapeutics Players Market Share by Revenue
3.6.3 Mergers & Acquisitions, Expansion
4 Migraine Therapeutics Industry Chain Analysis
4.1 Migraine Therapeutics Industry Chain Analysis
4.2 Market Overview of Key Raw Materials
4.3 Midstream Market Analysis
4.4 Downstream Customer Analysis
5 The Development and Dynamics of Migraine Therapeutics Market
5.1 Key Development Trends
5.2 Driving Factors
5.3 Market Challenges
5.4 Market Restraints
5.5 Industry News
5.5.1 New Product Developments
5.5.2 Mergers & Acquisitions
5.5.3 Expansions
5.5.4 Collaboration/Supply Contracts
5.6 Industry Policies
6 Migraine Therapeutics Market Segmentation by Type
6.1 Evaluation Matrix of Segment Market Development Potential (Type)
6.2 Global Migraine Therapeutics Sales Market Share by Type (2019-2024)
6.3 Global Migraine Therapeutics Market Size Market Share by Type (2019-2024)
6.4 Global Migraine Therapeutics Price by Type (2019-2024)
7 Migraine Therapeutics Market Segmentation by Application
7.1 Evaluation Matrix of Segment Market Development Potential (Application)
7.2 Global Migraine Therapeutics Market Sales by Application (2019-2024)
7.3 Global Migraine Therapeutics Market Size (M USD) by Application (2019-2024)
7.4 Global Migraine Therapeutics Sales Growth Rate by Application (2019-2024)
8 Migraine Therapeutics Market Segmentation by Region
8.1 Global Migraine Therapeutics Sales by Region
8.1.1 Global Migraine Therapeutics Sales by Region
8.1.2 Global Migraine Therapeutics Sales Market Share by Region
8.2 North America
8.2.1 North America Migraine Therapeutics Sales by Country
8.2.2 U.S.
8.2.3 Canada
8.2.4 Mexico
8.3 Europe
8.3.1 Europe Migraine Therapeutics Sales by Country
8.3.2 Germany
8.3.3 France
8.3.4 U.K.
8.3.5 Italy
8.3.6 Russia
8.4 Asia Pacific
8.4.1 Asia Pacific Migraine Therapeutics Sales by Region
8.4.2 China
8.4.3 Japan
8.4.4 South Korea
8.4.5 India
8.4.6 Southeast Asia
8.5 South America
8.5.1 South America Migraine Therapeutics Sales by Country
8.5.2 Brazil
8.5.3 Argentina
8.5.4 Columbia
8.6 Middle East and Africa
8.6.1 Middle East and Africa Migraine Therapeutics Sales by Region
8.6.2 Saudi Arabia
8.6.3 UAE
8.6.4 Egypt
8.6.5 Nigeria
8.6.6 South Africa
9 Key Companies Profile
9.1 Allergan
9.1.1 Allergan Migraine Therapeutics Basic Information
9.1.2 Allergan Migraine Therapeutics Product Overview
9.1.3 Allergan Migraine Therapeutics Product Market Performance
9.1.4 Allergan Business Overview
9.1.5 Allergan Migraine Therapeutics SWOT Analysis
9.1.6 Allergan Recent Developments
9.2 Merck
9.2.1 Merck Migraine Therapeutics Basic Information
9.2.2 Merck Migraine Therapeutics Product Overview
9.2.3 Merck Migraine Therapeutics Product Market Performance
9.2.4 Merck Business Overview
9.2.5 Merck Migraine Therapeutics SWOT Analysis
9.2.6 Merck Recent Developments
9.3 Pfizer
9.3.1 Pfizer Migraine Therapeutics Basic Information
9.3.2 Pfizer Migraine Therapeutics Product Overview
9.3.3 Pfizer Migraine Therapeutics Product Market Performance
9.3.4 Pfizer Migraine Therapeutics SWOT Analysis
9.3.5 Pfizer Business Overview
9.3.6 Pfizer Recent Developments
9.4 Teva
9.4.1 Teva Migraine Therapeutics Basic Information
9.4.2 Teva Migraine Therapeutics Product Overview
9.4.3 Teva Migraine Therapeutics Product Market Performance
9.4.4 Teva Business Overview
9.4.5 Teva Recent Developments
9.5 Amgen
9.5.1 Amgen Migraine Therapeutics Basic Information
9.5.2 Amgen Migraine Therapeutics Product Overview
9.5.3 Amgen Migraine Therapeutics Product Market Performance
9.5.4 Amgen Business Overview
9.5.5 Amgen Recent Developments
9.6 Johnson and Johnson
9.6.1 Johnson and Johnson Migraine Therapeutics Basic Information
9.6.2 Johnson and Johnson Migraine Therapeutics Product Overview
9.6.3 Johnson and Johnson Migraine Therapeutics Product Market Performance
9.6.4 Johnson and Johnson Business Overview
9.6.5 Johnson and Johnson Recent Developments
9.7 Endo International
9.7.1 Endo International Migraine Therapeutics Basic Information
9.7.2 Endo International Migraine Therapeutics Product Overview
9.7.3 Endo International Migraine Therapeutics Product Market Performance
9.7.4 Endo International Business Overview
9.7.5 Endo International Recent Developments
9.8 GlaxoSmithKline
9.8.1 GlaxoSmithKline Migraine Therapeutics Basic Information
9.8.2 GlaxoSmithKline Migraine Therapeutics Product Overview
9.8.3 GlaxoSmithKline Migraine Therapeutics Product Market Performance
9.8.4 GlaxoSmithKline Business Overview
9.8.5 GlaxoSmithKline Recent Developments
9.9 Impax
9.9.1 Impax Migraine Therapeutics Basic Information
9.9.2 Impax Migraine Therapeutics Product Overview
9.9.3 Impax Migraine Therapeutics Product Market Performance
9.9.4 Impax Business Overview
9.9.5 Impax Recent Developments
9.10 Abbott
9.10.1 Abbott Migraine Therapeutics Basic Information
9.10.2 Abbott Migraine Therapeutics Product Overview
9.10.3 Abbott Migraine Therapeutics Product Market Performance
9.10.4 Abbott Business Overview
9.10.5 Abbott Recent Developments
9.11 Bayer
9.11.1 Bayer Migraine Therapeutics Basic Information
9.11.2 Bayer Migraine Therapeutics Product Overview
9.11.3 Bayer Migraine Therapeutics Product Market Performance
9.11.4 Bayer Business Overview
9.11.5 Bayer Recent Developments
9.12 Eli Lilly
9.12.1 Eli Lilly Migraine Therapeutics Basic Information
9.12.2 Eli Lilly Migraine Therapeutics Product Overview
9.12.3 Eli Lilly Migraine Therapeutics Product Market Performance
9.12.4 Eli Lilly Business Overview
9.12.5 Eli Lilly Recent Developments
9.13 Novartis International
9.13.1 Novartis International Migraine Therapeutics Basic Information
9.13.2 Novartis International Migraine Therapeutics Product Overview
9.13.3 Novartis International Migraine Therapeutics Product Market Performance
9.13.4 Novartis International Business Overview
9.13.5 Novartis International Recent Developments
9.14 Ethypharm
9.14.1 Ethypharm Migraine Therapeutics Basic Information
9.14.2 Ethypharm Migraine Therapeutics Product Overview
9.14.3 Ethypharm Migraine Therapeutics Product Market Performance
9.14.4 Ethypharm Business Overview
9.14.5 Ethypharm Recent Developments
9.15 Kowa Pharmaceuticals America
9.15.1 Kowa Pharmaceuticals America Migraine Therapeutics Basic Information
9.15.2 Kowa Pharmaceuticals America Migraine Therapeutics Product Overview
9.15.3 Kowa Pharmaceuticals America Migraine Therapeutics Product Market Performance
9.15.4 Kowa Pharmaceuticals America Business Overview
9.15.5 Kowa Pharmaceuticals America Recent Developments
9.16 Winston Pharmaceuticals
9.16.1 Winston Pharmaceuticals Migraine Therapeutics Basic Information
9.16.2 Winston Pharmaceuticals Migraine Therapeutics Product Overview
9.16.3 Winston Pharmaceuticals Migraine Therapeutics Product Market Performance
9.16.4 Winston Pharmaceuticals Business Overview
9.16.5 Winston Pharmaceuticals Recent Developments
9.17 AstraZeneca
9.17.1 AstraZeneca Migraine Therapeutics Basic Information
9.17.2 AstraZeneca Migraine Therapeutics Product Overview
9.17.3 AstraZeneca Migraine Therapeutics Product Market Performance
9.17.4 AstraZeneca Business Overview
9.17.5 AstraZeneca Recent Developments
9.18 Amirall
9.18.1 Amirall Migraine Therapeutics Basic Information
9.18.2 Amirall Migraine Therapeutics Product Overview
9.18.3 Amirall Migraine Therapeutics Product Market Performance
9.18.4 Amirall Business Overview
9.18.5 Amirall Recent Developments
9.19 OptiNose
9.19.1 OptiNose Migraine Therapeutics Basic Information
9.19.2 OptiNose Migraine Therapeutics Product Overview
9.19.3 OptiNose Migraine Therapeutics Product Market Performance
9.19.4 OptiNose Business Overview
9.19.5 OptiNose Recent Developments
9.20 Revance Therapeutics
9.20.1 Revance Therapeutics Migraine Therapeutics Basic Information
9.20.2 Revance Therapeutics Migraine Therapeutics Product Overview
9.20.3 Revance Therapeutics Migraine Therapeutics Product Market Performance
9.20.4 Revance Therapeutics Business Overview
9.20.5 Revance Therapeutics Recent Developments
9.21 RedHill Biopharma
9.21.1 RedHill Biopharma Migraine Therapeutics Basic Information
9.21.2 RedHill Biopharma Migraine Therapeutics Product Overview
9.21.3 RedHill Biopharma Migraine Therapeutics Product Market Performance
9.21.4 RedHill Biopharma Business Overview
9.21.5 RedHill Biopharma Recent Developments
9.22 Bausch Health
9.22.1 Bausch Health Migraine Therapeutics Basic Information
9.22.2 Bausch Health Migraine Therapeutics Product Overview
9.22.3 Bausch Health Migraine Therapeutics Product Market Performance
9.22.4 Bausch Health Business Overview
9.22.5 Bausch Health Recent Developments
9.23 NeurAxon
9.23.1 NeurAxon Migraine Therapeutics Basic Information
9.23.2 NeurAxon Migraine Therapeutics Product Overview
9.23.3 NeurAxon Migraine Therapeutics Product Market Performance
9.23.4 NeurAxon Business Overview
9.23.5 NeurAxon Recent Developments
9.24 Biohaven Pharma
9.24.1 Biohaven Pharma Migraine Therapeutics Basic Information
9.24.2 Biohaven Pharma Migraine Therapeutics Product Overview
9.24.3 Biohaven Pharma Migraine Therapeutics Product Market Performance
9.24.4 Biohaven Pharma Business Overview
9.24.5 Biohaven Pharma Recent Developments
9.25 Eisai
9.25.1 Eisai Migraine Therapeutics Basic Information
9.25.2 Eisai Migraine Therapeutics Product Overview
9.25.3 Eisai Migraine Therapeutics Product Market Performance
9.25.4 Eisai Business Overview
9.25.5 Eisai Recent Developments
9.26 Valeant Pharma
9.26.1 Valeant Pharma Migraine Therapeutics Basic Information
9.26.2 Valeant Pharma Migraine Therapeutics Product Overview
9.26.3 Valeant Pharma Migraine Therapeutics Product Market Performance
9.26.4 Valeant Pharma Business Overview
9.26.5 Valeant Pharma Recent Developments
10 Migraine Therapeutics Market Forecast by Region
10.1 Global Migraine Therapeutics Market Size Forecast
10.2 Global Migraine Therapeutics Market Forecast by Region
10.2.1 North America Market Size Forecast by Country
10.2.2 Europe Migraine Therapeutics Market Size Forecast by Country
10.2.3 Asia Pacific Migraine Therapeutics Market Size Forecast by Region
10.2.4 South America Migraine Therapeutics Market Size Forecast by Country
10.2.5 Middle East and Africa Forecasted Consumption of Migraine Therapeutics by Country
11 Forecast Market by Type and by Application (2025-2030)
11.1 Global Migraine Therapeutics Market Forecast by Type (2025-2030)
11.1.1 Global Forecasted Sales of Migraine Therapeutics by Type (2025-2030)
11.1.2 Global Migraine Therapeutics Market Size Forecast by Type (2025-2030)
11.1.3 Global Forecasted Price of Migraine Therapeutics by Type (2025-2030)
11.2 Global Migraine Therapeutics Market Forecast by Application (2025-2030)
11.2.1 Global Migraine Therapeutics Sales (K Units) Forecast by Application
11.2.2 Global Migraine Therapeutics Market Size (M USD) Forecast by Application (2025-2030)
12 Conclusion and Key Findings